new drug pumps in prospect
Oral therapies for Parkinson's are limited in time because, among other things, Parkinson's disease is a progressive neurodegenerative disease. Over time, the progressive loss of dopamine-producing neurons in the brain leads to worsening symptoms. The effects of oral medications such as levodopa can be well controlled in the early stages of the disease. However, many patients develop fluctuations in the effectiveness of the medication over time, known as the “on-off phenomenon.” These fluctuations can Quality of life significantly impair and lead to unpredictable fluctuations in movement abilities.